Title of article :
Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
Author/Authors :
Augustovski ، Federico Institute for Clinical Effectiveness and Health Policy (IECS-CONICET) , Colantonio ، Lisandro D. University of Alabama at Birmingham , Galante ، Julieta Cardiff University , Bardach ، Ariel Institute for Clinical Effectiveness and Health Policy (IECS-CONICET) , Caporale ، Joaquín E. Institute for Clinical Effectiveness and Health Policy (IECS-CONICET) , Zárate ، Víctor - Universidad San Sebastian , Hsiang Chuang ، Ling , Pichon Riviere ، Andres Institute for Clinical Effectiveness and Health Policy (IECS-CONICET) , Kind ، Paul University of Leeds
Pages :
17
From page :
120
To page :
136
Abstract :
Background The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using qualityadjusted life years (QALYs) or disabilityadjusted life years (DALYs) as benefit metrics and their potential impact in decisionmaking.   Methods Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ5D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = 73) to obtain EQ5D data for all health states included in both models. Several scenario analyses were carriedout to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations.   Results QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and ageweighting – scenario with greatest differences in all countries – incremental DALYs avoided represented the 75%, 68%, and 43% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decisionmaking using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds.   Conclusion We did not find evidence that contradicts current practice of many researchers and decisionmakers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions.
Keywords :
Quality , Adjusted Life Year (QALY) , Disability , Adjusted Life Year (DALY) , Health Benefit Measure , Economic Evaluation
Journal title :
International Journal of Health Policy and Management
Serial Year :
2018
Journal title :
International Journal of Health Policy and Management
Record number :
2459937
Link To Document :
بازگشت